MDCK cells express serotonin-regulable 11beta-hydroxysteroid dehydrogenase type 2

Marisa L Zallocchil1, Maria C Damasco, Juan C Calvo

  • 1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires and PRHOM-CONICET, Buenos Aires, Argentina.

Insights

Stressful situations activate renal 11beta-hydroxysteroid dehydrogenase 2 (11β-HSD2) via extra-adrenal factors like serotonin. This serotonin-mediated regulation of 11β-HSD2 activity may prevent glucocorticoid-induced hypertension.

Area of Science:

  • Endocrinology
  • Neuroendocrinology
  • Renal Physiology

Background:

  • Stressful situations activate adrenal and extra-adrenal factors influencing renal 11beta-hydroxysteroid dehydrogenase 2 (11β-HSD2) activity.
  • The enzyme 11β-HSD2 protects mineralocorticoid receptors from glucocorticoid overactivation, preventing sodium retention and hypertension.

Purpose of the Study:

  • To investigate the role of serotonin as an extra-adrenal factor modulating 11β-HSD2 activity.
  • To understand the mechanism by which serotonin influences renal 11β-HSD2 in stressful conditions.

Main Methods:

  • Utilized a cell line derived from polarized-epithelium of the distal nephron.
  • Assessed 11β-HSD2 activity using 3H-corticosterone as a substrate, with product quantification via HPLC.
  • Investigated serotonin's effects at varying concentrations (2nM, 25pM) and substrate levels, employing specific inhibitors (methiothepin, ketanserin).

Main Results:

  • Serotonin significantly stimulated 11β-HSD2 activity at specific concentrations (2nM and 25pM).
  • The magnitude of serotonin's stimulatory effect was dependent on substrate concentration.
  • Inhibitors methiothepin and ketanserin blocked serotonin-induced stimulation of 11β-HSD2 activity.

Conclusions:

  • Serotonin acts as a key extra-adrenal factor regulating renal 11β-HSD2 activity.
  • Serotonin-mediated catabolic regulation of 11β-HSD2 may prevent mineralocorticoid receptor over-occupancy by elevated glucocorticoids during stress.
  • This interaction suggests a potential novel regulatory axis involving serotonin and glucocorticoids in renal physiology.